IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed: Guidance for IRBs, Clinical Investigators, and Sponsors

Information

Type

Guidance

Regulated products

Biologics, Drugs, Medical Devices

Topics

Administrative / Procedural, Good Clinical Practice (GCP)

Published

August 27, 2013

Last updated

July 22, 2021

Description

This document provides guidance for IRBs, clinical investigators, and sponsors on IRB responsibilities and GCP in reviewing qualifications and research sites.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed